<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC6941257/table_2" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 2</label>
  <p>A summary of several aptamers developed for the treatment of viral infections by SELEX method</p>
 </caption>
 <thead>
  <tr>
   <th colspan="1" rowspan="1" id="0-0-.">Organism</th>
   <th colspan="1" rowspan="1" id="0-1-.">Type of aptamer</th>
   <th colspan="1" rowspan="1" id="0-2-.">Target</th>
   <th colspan="1" rowspan="1" id="0-3-.">Aptamer therapeutic effect</th>
   <th colspan="1" rowspan="1" id="0-4-.">Ref</th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td>HBV</td>
   <td>DNA</td>
   <td>Core protein</td>
   <td>
    <p>-Prevent the assembly of the nucleocapsid</p>
    <p>-function by suppressing HBV replication</p>
   </td>
   <td>[ 
    <a ref-type="bibr" rid="CR82">82</a>] 
   </td>
  </tr>
  <tr>
   <td>HCV</td>
   <td>DNA</td>
   <td>Envelope Protein</td>
   <td>-Inhibition of virus binding to host cells</td>
   <td>[ 
    <a ref-type="bibr" rid="CR90">90</a>] 
   </td>
  </tr>
  <tr>
   <td>Influenza A virus</td>
   <td>DNA</td>
   <td>Hemagglutinin protein</td>
   <td>
    <p>-Blocking the binding of</p>
    <p>virus to target cell receptors</p>
    <p>-prevention of the virus invasion into the host cells</p>
   </td>
   <td>[ 
    <a ref-type="bibr" rid="CR83">83</a>] 
   </td>
  </tr>
  <tr>
   <td>Ebola Virus</td>
   <td>RNA</td>
   <td>VP35</td>
   <td>-Disrupt the eVP35âˆ’ NP interaction</td>
   <td>[ 
    <a ref-type="bibr" rid="CR91">91</a>] 
   </td>
  </tr>
  <tr>
   <td>HIV-1</td>
   <td>RNA</td>
   <td>gag protein</td>
   <td>-Inhibit HIV-1 replication</td>
   <td>[ 
    <a ref-type="bibr" rid="CR92">92</a>] 
   </td>
  </tr>
  <tr>
   <td>HSV-1</td>
   <td>RNA</td>
   <td>gD protein</td>
   <td>-Blocking the gD functions</td>
   <td>[ 
    <a ref-type="bibr" rid="CR85">85</a>] 
   </td>
  </tr>
  <tr>
   <td>Vaccinia virus</td>
   <td>DNA</td>
   <td>Hemagglutinin protein</td>
   <td>
    <p>-Recognize proteins</p>
    <p>expressed on the surface of VV- infected cells</p>
   </td>
   <td>[ 
    <a ref-type="bibr" rid="CR93">93</a>] 
   </td>
  </tr>
  <tr>
   <td>Influenza B Virus</td>
   <td>RNA</td>
   <td>Hemagglutinin protein</td>
   <td>-Inhibited HA-mediated membrane fusion</td>
   <td>[ 
    <a ref-type="bibr" rid="CR94">94</a>] 
   </td>
  </tr>
  <tr>
   <td>SCV</td>
   <td>RNA</td>
   <td>nsP10</td>
   <td>-Inhibit double-stranded DNA unwinding activity of the helicase</td>
   <td>[ 
    <a ref-type="bibr" rid="CR89">89</a>] 
   </td>
  </tr>
  <tr>
   <td>Rabies virus</td>
   <td>DNA</td>
   <td>
    <p>Blocking the interaction</p>
    <p>between rabies virus and permissive host cell receptors</p>
   </td>
   <td>-Reduced viral replication in an in vitro infection model</td>
   <td>[ 
    <a ref-type="bibr" rid="CR84">84</a>] 
   </td>
  </tr>
 </tbody>
 <tfoot>
  <p>
   <i>VP35</i> viral protein 35, 
   <i>NP</i> nucleoprotein, 
   <i>nsP10</i> NTPase/Helicase 
  </p>
 </tfoot>
</table>
